JP2025026843A5 - - Google Patents
Info
- Publication number
- JP2025026843A5 JP2025026843A5 JP2024185014A JP2024185014A JP2025026843A5 JP 2025026843 A5 JP2025026843 A5 JP 2025026843A5 JP 2024185014 A JP2024185014 A JP 2024185014A JP 2024185014 A JP2024185014 A JP 2024185014A JP 2025026843 A5 JP2025026843 A5 JP 2025026843A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- antibody
- antigen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962871031P | 2019-07-05 | 2019-07-05 | |
| US62/871,031 | 2019-07-05 | ||
| US202063025096P | 2020-05-14 | 2020-05-14 | |
| US63/025,096 | 2020-05-14 | ||
| JP2022500544A JP7579589B2 (ja) | 2019-07-05 | 2020-07-02 | Ｒａｎタンパク質関連神経学的疾患を処置するための方法 |
| PCT/US2020/040725 WO2021007110A1 (en) | 2019-07-05 | 2020-07-02 | Methods for treating ran protein-associated neurological diseases |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022500544A Division JP7579589B2 (ja) | 2019-07-05 | 2020-07-02 | Ｒａｎタンパク質関連神経学的疾患を処置するための方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025026843A JP2025026843A (ja) | 2025-02-26 |
| JP2025026843A5 true JP2025026843A5 (enExample) | 2025-09-29 |
Family
ID=74114201
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022500544A Active JP7579589B2 (ja) | 2019-07-05 | 2020-07-02 | Ｒａｎタンパク質関連神経学的疾患を処置するための方法 |
| JP2024185014A Pending JP2025026843A (ja) | 2019-07-05 | 2024-10-21 | Ｒａｎタンパク質関連神経学的疾患を処置するための方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022500544A Active JP7579589B2 (ja) | 2019-07-05 | 2020-07-02 | Ｒａｎタンパク質関連神経学的疾患を処置するための方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20220267776A1 (enExample) |
| EP (1) | EP3994159A4 (enExample) |
| JP (2) | JP7579589B2 (enExample) |
| AU (1) | AU2020310843A1 (enExample) |
| CA (1) | CA3145291A1 (enExample) |
| WO (1) | WO2021007110A1 (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10509045B2 (en) | 2015-05-29 | 2019-12-17 | University Of Florida Research Foundation, Incorporated | Methods for diagnosing Huntington's disease |
| AU2017246643B2 (en) | 2016-04-04 | 2022-08-04 | University Of Florida Research Foundation, Incorporated | Manipulation of eIF3 to modulate repeat associated non-ATG (RAN) translation |
| US11345911B2 (en) | 2017-04-17 | 2022-05-31 | University Of Florida Research Foundation, Incorporated | Regulation of RAN translation by PKR and eIF2A-P pathways |
| WO2019023247A1 (en) | 2017-07-25 | 2019-01-31 | Immutics, Inc. | TREATMENT OF CANCER BY BLOCKING THE INTERACTION OF TIM-3 AND ITS LIGAND |
| EP3688021A4 (en) | 2017-09-26 | 2021-12-29 | University of Florida Research Foundation, Incorporated | Use of metformin and analogs thereof to reduce ran protein levels in the treatment of neurological disorders |
| EP3918323A4 (en) | 2019-01-30 | 2022-12-28 | TrueBinding, Inc. | ANTI-GAL3 ANTIBODIES AND USES THEREOF |
| EP4031562A4 (en) | 2019-09-20 | 2023-11-01 | University of Florida Research Foundation, Incorporated | DETECTION OF ANTIBODIES AGAINST RAN PROTEINS FROM SERUM AND TISSUE LYSATES |
| WO2021242776A2 (en) | 2020-05-26 | 2021-12-02 | Truebinding, Inc. | Methods of treating inflammatory diseases by blocking galectin-3 |
| WO2023077153A1 (en) * | 2021-11-01 | 2023-05-04 | University Of Florida Research Foundation, Incorporated | Poly-ga proteins in alzheimer's disease |
| EP4440560A1 (en) | 2021-12-01 | 2024-10-09 | University Of Florida Research Foundation, Incorporated | Small molecule inhibitors of repeat associated non-aug (ran) translation and combination therapies |
| WO2024097756A1 (en) * | 2022-11-01 | 2024-05-10 | University Of Florida Research Foundation, Incorporated | Interrupted ran proteins in disease |
| WO2024173816A1 (en) * | 2023-02-17 | 2024-08-22 | The University Of North Carolina At Chapel Hill | Methods of detecting telomere-encoded dipeptide repeat proteins and therapeutic applications |
| CN116693621B (zh) * | 2023-03-02 | 2023-11-14 | 东北农业大学 | 抑制革兰氏阴性菌的窄谱抗菌肽pc及其制备方法和应用 |
| WO2025019730A1 (en) * | 2023-07-20 | 2025-01-23 | University Of Florida Research Foundation, Incorporated | Engineered ga antibodies for therapy development |
| WO2025128551A1 (en) * | 2023-12-11 | 2025-06-19 | University Of Florida Research Foundation, Incorporated | Aav-based anti-ga therapy |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUE046434T2 (hu) | 2013-01-22 | 2020-03-30 | Deutsches Zentrum Fuer Neurodegenerative Erkrankungen E V | Dipeptid-ismétlõdõ fehérjék terápiás célpontként neurodegeneratív betegségekben, hexanukleotid ismétlõdõ expanzióval |
| HK1220227A1 (zh) * | 2013-03-14 | 2017-04-28 | University Of Florida Research Foundation, Inc. | 与als有关的重复含有蛋白质的二氨基酸 |
| MX2017001531A (es) * | 2014-08-08 | 2017-05-15 | Alector Llc | Anticuerpos anti-trem2 y metodos de uso de los mismos. |
| JP6432023B2 (ja) | 2014-12-02 | 2018-12-05 | 国立大学法人 東京医科歯科大学 | 脊髄小脳失調症３１型（ｓｃａ３１）治療剤 |
| US10509045B2 (en) * | 2015-05-29 | 2019-12-17 | University Of Florida Research Foundation, Incorporated | Methods for diagnosing Huntington's disease |
| AU2017246643B2 (en) * | 2016-04-04 | 2022-08-04 | University Of Florida Research Foundation, Incorporated | Manipulation of eIF3 to modulate repeat associated non-ATG (RAN) translation |
| WO2019032612A1 (en) * | 2017-08-08 | 2019-02-14 | Wave Life Sciences Ltd. | OLIGONUCLEOTIDE COMPOSITIONS AND ASSOCIATED METHODS |
| JP2020535448A (ja) * | 2017-09-25 | 2020-12-03 | ユニバーシティー オブ フロリダ リサーチ ファンデーション， インク． | Ｒａｎタンパク質の検出のための免役アッセイ |
| EP3688021A4 (en) * | 2017-09-26 | 2021-12-29 | University of Florida Research Foundation, Incorporated | Use of metformin and analogs thereof to reduce ran protein levels in the treatment of neurological disorders |
-
2020
- 2020-07-02 EP EP20836437.2A patent/EP3994159A4/en active Pending
- 2020-07-02 WO PCT/US2020/040725 patent/WO2021007110A1/en not_active Ceased
- 2020-07-02 US US17/624,700 patent/US20220267776A1/en active Pending
- 2020-07-02 AU AU2020310843A patent/AU2020310843A1/en active Pending
- 2020-07-02 JP JP2022500544A patent/JP7579589B2/ja active Active
- 2020-07-02 CA CA3145291A patent/CA3145291A1/en active Pending
-
2024
- 2024-10-21 JP JP2024185014A patent/JP2025026843A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025026843A5 (enExample) | ||
| TWI789644B (zh) | 抗－N3pGlu類澱粉β肽抗體及其用途 | |
| TWI374893B (en) | Humanized antibodies that recognize beta amyloid peptide | |
| CN105849124B (zh) | 双重特异性抗体 | |
| ES2664128T3 (es) | Anticuerpos anti péptido Beta Amiloide N3pGlu y usos de los mismos | |
| KR101681910B1 (ko) | Ｒｇｍ ａ 단백질에 대한 모노클로날 항체 및 이의 용도 | |
| JP2020023523A5 (enExample) | ||
| TW201525004A (zh) | 結合前蛋白轉化酶枯草桿菌蛋白酶加工酶９型之人類抗原結合蛋白 | |
| JP2003523764A5 (enExample) | ||
| KR20150080033A (ko) | 골관절염 및 통증의 치료 방법 | |
| JP2016007218A (ja) | 改善された抗ｔｎｆｒ１ポリペプチド、抗体可変ドメインおよびアンタゴニスト | |
| JP2007097598A5 (enExample) | ||
| JP2009535021A5 (enExample) | ||
| US20220372127A1 (en) | Aqueous pharmaceutical composition of an anti-il17a antibody and use thereof | |
| WO2012109280A2 (en) | Apoe immunotherapy | |
| US20250171557A1 (en) | Therapeutic agent for neurodegenerative disorder | |
| JPWO2020011966A5 (enExample) | ||
| WO2016201434A2 (en) | Stable formulations of humanized anti-tau antibody | |
| US20200308258A1 (en) | Anti-herv-k envelope antibody and uses thereof | |
| JP2020527152A5 (enExample) | ||
| JPWO2021007110A5 (enExample) | ||
| JPWO2018206790A5 (enExample) | ||
| CN113518626B (zh) | 用于治疗黄热病的方法和组合物 | |
| CN110114370A (zh) | 能够与人白细胞介素-6受体结合的抗体或其抗原结合片段 | |
| JP6134392B2 (ja) | 循環している生物学的に活性な可溶性ｔｎｆの選択的低減用の組成物およびｔｎｆ媒介性疾患を処置する方法 |